Company / Working Capital
IRONWOOD PHARMACEUTICALS INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$32.0M
FY2025
5-year range
-$42.8M / $755.1M
FY2021-FY2025
Trend
-77.7%
vs FY2024
Sector context
#204 of 213
Health Care
What the data says
Among 213 Health Care companies, IRONWOOD PHARMACEUTICALS INC is in the bottom 4% for working capital. Working Capital has fluctuated over the past 10 years, ranging from -$43M in FY2023 to $755M in FY2022.
Based on SEC 10-K filings.
$32M in FY2025 with a 5-year CAGR of -41.4%.
Improved from -$43M to $32M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -65.2%
- 5-Year CAGR
- -41.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 213This company $32.0M Sector average $934.6M
▼
-96.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -41.4%, indicating a declining trend.
- In FY2025, working capital decreased 77.7% year-over-year.
- Ranks #204 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.0M | -77.7% |
| FY2024 | $143.5M | +435.2% |
| FY2023 | -$42.8M | -105.7% |
| FY2022 | $755.1M | +29.4% |
| FY2021 | $583.5M | +25.9% |
| FY2020 | $463.7M | +74.4% |
| FY2019 | $265.9M | +81.0% |
| FY2018 | $146.9M | -40.2% |
| FY2017 | $245.6M | -15.0% |
| FY2016 | $289.1M | -31.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026